Could a simple ear reflex test improve cochlear implants for kids?

NCT ID NCT07417956

Recruiting now Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study looks at whether measuring the stapedius reflex (a tiny ear muscle reflex) can help program cochlear implants in children aged 0 to 7. Currently, programming relies on behavioral responses, which can be hard to get from very young kids. The researchers will test the reflex during routine follow-up visits at 3, 6, and 12 months after surgery. If the method is reliable, it could lead to better hearing and speech outcomes for children with hearing loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Electrically evoked stapedius reflex threshold (eSRT) measurement
What this could lead to: If successful, this could make cochlear implant programming faster and more accurate for young children, potentially improving speech development.
What could go wrong: This is a small, early feasibility study with only 48 children. The measurement may not work in all kids or may not lead to better outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEARING LOSS IN CHILDREN WITH UNILATERAL OR BILATERAL COCHLEAR IMPLANTS

Contacts and locations

Locations

Hôpital Necker Enfants Malades - Service d'ORL et chirurgie cervico-faciale
RECRUITING

Paris, Île-de-France Region, 75015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.